A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD
Clinical trial NCT02815488 · TERMINATED
Trial details
- NCT number
- NCT02815488
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-22
- Primary completion
- 2019-03-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.